Hester Biosciences Limited

HESTERBIO

INE782E01017

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:44 20/06/2025 pm IST			5-day change	1st Jan Change
1,747.20 ^INR	-1.59%		-6.02%	-27.01%

17/05	Hester Biosciences Limited, Q4 2025 Earnings Call, May 09, 2025
09/05	Hester Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI

Hester Biosciences Acquires Indigenous Technology for Avian Influenza Vaccine

Published on 28/12/2022 at 11:56, updated on 28/12/2022 at 11:57

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Hester Biosciences Limited

Hester Biosciences Limited, Q4 2025 Earnings Call, May 09, 2025	17/05
Hester Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2025	09/05	CI
Hester Biosciences Limited Approves Shifting of Registered Office	14/02	CI
Hester Biosciences Limited, Q3 2025 Earnings Call, Jan 30, 2025	30/01
Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	30/01	CI
Hester Biosciences Receives A Demand Notice from Assistant Commissioner, CGST Division Panchkula, Haryana	21/01	CI
Hester Biosciences Limited Announces Resignation of Ram Prakash as Chief Operating Officer	24/12	CI
Hester Biosciences Limited Appoints Divyesh Maru as Chief Financial Officer	12/11	CI
Hester Biosciences' CFO Resigns	31/24/31	MT
Hester Biosciences Limited Announces Resignation of Nikhil Jhanwar as Chief Financial Officer, Effective 29 November 2024	30/24/30	CI
Hester Biosciences Limited, Q2 2025 Earnings Call, Oct 28, 2024	28/24/28
Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	28/24/28	CI
Hester Biosciences Limited Receives Penalty from Additional Commissioner, Office of the Commissioner of Central Tax Audit, Ahmedabad	10/24/10	CI
Hester Biosciences Limited, Q1 2025 Earnings Call, Aug 02, 2024	02/24/02
Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	02/24/02	CI
Hester Biosciences Limited, Q4 2024 Earnings Call, May 10, 2024	10/24/10
Hester Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	10/24/10	CI
Hester Biosciences Names COO	29/24/29	MT
Hester Biosciences Limited Announces Executive Changes	29/24/29	CI
Hester Biosciences Sees Sharp Decline in Fiscal Q3 Consolidated Profit	02/24/02	MT
Hester Biosciences Limited, Q3 2024 Earnings Call, Feb 02, 2024	02/24/02
Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02/24/02	CI
CARE Ratings Keeps BBB+ Rating on Hester Biosciences' Bank Financing; Outlook Stable	03/24/03	MT
Hester Biosciences Limited, Q2 2024 Earnings Call, Nov 07, 2023	07/23/07
Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	07/23/07	CI

Chart Hester Biosciences Limited

Duration

Period

HESTERBIO: Dynamic Chart

Hester Biosciences Limited is an India-based animal healthcare company. The Company is principally engaged in manufacturing poultry vaccines, large animal vaccines, and trading poultry, large animal, and petcare health products. It operates through three segments: Poultry Healthcare, Animal Healthcare, and Petcare. The Poultry Healthcare vaccines include Gumboro I, Inactivated Chick ND, Inactivated Coryza, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, and Inactivated IBD. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Pawfresh, Synoton, Petsglow, and Vitacoat. The Company also operates diagnostic labs for poultry and provides diagnostic kits for sero-surveillance and mastitis prevention for cattle farms. Its manufacturing facility is located at Meda Adraj Village, Mehsana District, Gujarat.

Employees

642

Sector

Pharmaceuticals

Calendar

31/07 - Q1 2026 Earnings Release (Projected)

More about the company